Although antibiotic prophylaxis following rhinoplasty is widespread, the evidence on antibiotic prophylaxis effectiveness and the superiority of particular administration regimens is controversial. To date, a meta-analysis on the topic has not been performed.
S urgical site infections are a significant clinical problem associated with elevated postoperative morbidity and demanding substantial use of health care resources. 1 To avoid postoperative infection, antibiotic prophylaxis following rhinoplasty is used in over 90% of the procedures. 2 While this practice is widespread, the evidence on antibiotic prophylaxis effectiveness and the superiority of particular administration regimens is controversial. It has previously been reported that 28% of rhinoplasty surgeons do not use antibiotics, 17% use them only perioperatively, 24% prescribe antibiotics up to 3 days after the surgical procedure, 31% administer them up to 7 days, and 3% use antibiotic irrigation. 3 Use of grafts in rhinoplasty has been associated with an even more prolonged use of postoperative antibiotics. 3 A narrative review by Georgiou et al 4 has advised against antibiotic prophylaxis after rhinoplasty. An extensive retrospective review by Cabouli et al 5 suggested a low rate of infection after rhinoplasty (0.6%) as a reason against routine postoperative antibiotic prophylaxis. A low incidence of postoperative infections (0.48%) has also been reported by Yoder and Weimert 6 among a mixed septoplasty/septorhinoplasty cohort. Slavin et al 7 have found no evidence of bacteremia after rhinoplasty. Published in 2017, a clinical practice guideline suggested that harm caused by routine postoperative antibiotics might outweigh the risks related to possible postoperative infection. 2 The clinical practice guideline cited 2 randomized clinical trials (RCTs) that reported no difference in infection incidence between groups. 8, 9 However, the clinical practice guideline included the results of a single trial on revision rhinoplasty that reported higher infection rates in the placebo group. 10 Thus, the clinical practice guideline has recommended against routine prescription of antibiotic therapy for more than 24 hours after the operation. 2 However, no definitive recommendations were offered concerning optimal preoperative, perioperative, or postoperative antibiotic prophylaxis in rhinoplasty. 2 To our knowledge, there have not been previous metaanalyses on the topic. The objective of this systematic review and meta-analysis was to investigate whether there is evidence that supports the routine use of postoperative antibiotic prophylaxis in rhinoplasty.
Methods
This review protocol was based on the Cochrane Handbook for Systematic Reviews of Interventions.
11 The population, intervention, comparison, and outcome criteria were defined as described below.
Population
Adults (age ≥18 years) undergoing rhinoplasty were the sample population. Rhinoplasty was understood as a surgical procedure that alters the shape or appearance of the nose while preserving or enhancing the nasal airway. The reasons for the procedure might be functional, cosmetic, or both. Adjunctive procedures on nasal septum, nasal turbinates, or paranasal sinuses alone, without an effect on nasal shape or appearance, were not considered rhinoplasty.
Types of Studies
Randomized clinical trials published in peer-reviewed academic journals with abstracts available and without restrictions on language or time of publication were included for analysis. Pilot reports, theses, conference proceedings, letters, editorials, and retrospective studies were excluded. Controlled clinical trials were included if the number of RCTs was less than 3.
Intervention
Systemic antibiotics administered in the absence of reasons for antibiotic use (eg, localized or systemic infection) other than preventing surgical complications were the interventions considered. Interventions of interest were classified as 3 types: (1) single-dose systemic antibiotic therapy administered within 24 hours before the first incision, (2) multidose systemic antibiotic treatment started within 24 hours before the first incision and continuing after the operation, and (3) a systemic antibiotic treatment (single dose or multidose) started within 24 hours after the first incision.
Comparison
For interventions of type 1, use vs no use of antibiotic was compared. For intervention types 2 and 3, use of no antibiotic or a type 1 intervention was compared. These interventions of interest were designed prior to search of the database.
Outcome
The outcome of the studies was difference in any infectious complication rate between groups. The risk rates of infections were reported as risk ratios (RRs).
Database Search Strategy
Without restriction on the time or language of publication, the databases of MEDLINE, Embase, CINAHL, Central (Cochrane Controlled Register of Trials), Scopus, and Web of Science were searched on February 16, 2018. All databases were searched from database inception. Search terms included rhinoplasty, nasal valve repair, and antimicrobial agents. Other terms are found in the eAppendix in the Supplement.
Key Points
Question What is the evidence from randomized clinical trials on effectiveness and appropriate administration of antibiotics in rhinoplasty procedures?
Findings In a systematic review and meta-analysis, a pooled study sample of 589 participants were extracted from 5 randomized clinical trials. Postoperative antibiotic therapy did not significantly alter the rate of infections after rhinoplasty procedures.
Meanings Based on these findings, preventive antibiotic therapy in rhinoplasty does not appear to be indicated.
Duplicates, conference proceedings, theses, and other publications that were not RCTs were excluded. Two independent reviewers (B.N. and C.K.K.) assessed the relevance of the remaining records, first based on titles and abstracts, and then based on full texts. Possible disagreements between the reviewers were resolved by consensus or by a decision made by a third reviewer (K.L.).
Data Extraction
The data needed for meta-analysis were extracted from the included trials using a standardized form based on recommendations by the Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0, part 7.6.
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Bias Assessments
The methodologic quality of the RCTs was assessed according to the Cochrane Collaboration's domain-based evaluation framework. 12 Main domains were assessed in the following sequence: (1) selection bias (randomized sequence generation and allocation concealment), (2) performance bias (blinding of participants and study personnel), (3) detection bias (blinding of outcome assessment), (4) attrition bias (eg, incomplete outcome data due to dropouts), (5) reporting bias (selective reporting), and (6) other sources of bias. The scores for each bias domain and the final score for risk of systematic bias were graded as low, high, or unclear. 13 
Statistical Analysis
The interrater reliability of independent author review of screened records was assessed using the κ statistic. The risk rates of infections in intervention and control groups are reported as RRs. The RRs were calculated along with their 95% CIs and 2-tailed P values considering findings significant at P < .05. The test for heterogeneity was conducted using the I 2 statistic describing the percentage of variation across studies originating more from heterogeneity than from chance. Potential publication bias was not analyzed because of the small number of identified trials. Expecting wide range of variability in studies' settings, a random-effects metasynthesis was used regardless of particular percentages of heterogeneity. The I 2 rank was classified as follows: 0% to 24%, no heterogeneity; 25% to 49%, low heterogeneity; 50% to 74%, moderate heterogeneity; and 75% or more, high heterogeneity. The analysis was conducted using Comprehensive Meta Analysis software, version 3.3 (Biostat; http://www.metaanalysis.com).
Results
The initial search yielded 252 records; 10 records were added from references of recent reviews. After exclusion of 64 duplicates, 198 records remained. Thirty-eight records were then excluded as not being RCTs (eg, conference proceedings, theses, case reports). The remaining 160 records were screened based on titles and abstracts with moderate κ of agreement 0.41 (SE, 0.11; 95% CI, 0.21-0.62). Twenty-three records were assessed based on their full texts. Finally, 5 studies were considered to be relevant for the qualitative and quantitative analysis ( Figure 1) . [8] [9] [10] 14, 15 The included RCTs were published between 1971 and 2006. The pooled sample consisted of 589 patients: 298 cases and 291 controls. Table 1 describes prophylactic antibiotic regimens used in the included trials. The most common antibiotics were penicillin or amoxicillin, with or without β-lactamase inhibition. Antibiotic treatments started on induction or perioperatively were administered intravenously, whereas therapy with antibiotics started postoperatively was administered orally. Dosages and durations varied with the duration of postoperative administration, ranging from 5 to 12 days. Two RCTs compared groups with antibiotic prophylaxis of different lengths of treatment, 8, 9 and 3 RCTs compared antibiotics with placebo or no treatment ( Table 2) . 10, 14, 15 The overall rate of infections within the pooled sample was 5.54% in cases and 6.53% in controls.
The eTable in the Supplement describes the risks of systematic bias among the RCTs. Of 5 studies, 4 were considered to have low risks. The overall risk of bias in the study by Weimert and Yoder 15 was considered unclear.
The pooled RR of infection when comparing postoperative antibiotics with any or all other antibiotic regimens in the RCTs, including placebo or no treatment, preoperative, or perioperative antibiotics is presented in Figure 2 . The pooled RR was 0.92 (95% CI, 0.35-2.43; P = .86) with low heterogeneity (I 2 = 44%). The pooled RR of infection when comparing postoperative antibiotics with placebo or no treatment (excluding preoperative or perioperative antibiotics) is presented in Figure 3 . The pooled RR was 0.43 (95% CI, 0.18-1.04; P = .06) with no heterogeneity observed (I 2 = 0%).
Discussion
In this systematic review and meta-analysis of 5 RCTs with overall low risks of systematic bias, routine antibiotic prophylaxis after rhinoplasty did not demonstrate an association with infection rates. The differences in RRs of infection were not statistically significant when comparing postoperative with preoperative and perioperative antibiotics or with placebo. The selected RCTs were notable regarding publication timing and the antibiogram landscape from which they arose. The most recent RCT included in this review was more than 10 years old, and the RCTs span 4 decades; this difference may affect the generalizability of the results as modern surgery, antibiotic assortment and doses, and national guidelines have significantly changed across the times studied. We noted in this review that, in general, the RCTs published more recently used antibiotics with wider extended-spectrum coverage than the older RCTs-this difference is perhaps the result of increasing concerns or evidence for antibiotic resistance and the greater need for effective antibiotic stewardship.
Parallel to concerns for antibiotic stewardship include a general global pandemic of multidrug-resistant infections, including methicillin-resistant Staphylococcus aureus (MRSA) infections. 16 While cases series of MRSA infections following rhinoplasty have been documented, 17 this issue has not been Prior studies report a range of postrhinoplasty infection from 0% to 26%, [4] [5] [6] 8, 9, 14, 15, 17, 18 with the largest retrospective reviews reporting infection rates as low as 0.6%. 5 This percentage is in contrast to our review's overall rate of infection among RCTs as 6.0%. This discrepancy, as well as prior literature's wide published range of dates, may be secondary to various factors. Studies prospectively defining infectious complications prior to outcome measurement were few, 8, 14 with only 1 RCT a priori explicitly classifying anticipated infectious complications. 8 Commonly, descriptions of postrhinoplasty infection mention peri-incisional purulence, frank abscess of any nasal compartment/subunit, nasal vestibulitis, and nasal cellulitis (Table 2) . However, specific measurement of other types of infectious complications vary widely among studies. For example, paranasal sinusitis is specifically identified as a postoperative infectious complication in few studies. 6, 14 In the selected RCTs, the breadth in specificity and variety of a defined infectious complication is notable ( Table 2 ). The higher rate of infection among the reviewed RCTs compared with prior literature also may be attributable to study design. All prior studies reporting infection rates from 0% to 0.6% were either retrospective medical record reviews or uncontrolled cohort studies, which are likely more susceptible to inherent differential biases, 4, 5, 7 in contrast to the selected RCTs and their overall low assessed bias (eTable in the Supplement).
The role of antibiotics in packing and/or splints post rhinoplasty is understudied. Among our selected RCTs, studies that mentioned packing had included it for all of their rhinoplasty patients. [8] [9] [10] Similarly, the study that mentioned inter- amoxicillin with clavulanate vs postoperative amoxicillin with clavulanate in "complex nasal surgery" only, which they defined as septorhinoplasty that involved nasal grafting and/or revision surgery, and found no difference in the incidence of infection. Schäfer and Pirsig 10 specifically examined postoperative propicillin vs placebo in revision rhinoplasty only, which in most cases in their cohort included septal reconstruction, osteotomies, wedge resection, and free "transplants" or grafting, and did find benefit to postoperative prophylaxis. The other RCT cohorts excluded or did not specify or quantify which patients underwent grafting or revision surgery. It is thus suggested that prophylactic therapy with antibiotics should be considered in revision cases or cases with grafting, but that perioperative administration may provide similar prophylactic benefit as postoperative administration. 8, 10 Further RCTs specifically investigating prophylaxis in grafting and revision rhinoplasty are needed.
Limitations
There are limitations to this meta-analysis. Pooling the results reported by different trials is always approximation. Even though the heterogeneity in this meta-analysis was small, the included studies varied in terms of their samples, settings, and antibiotic treatment regimens. Some of the included trials lacked precise descriptions of surgical techniques used (eg, the extent of grafting, a graft type, or revision rates). Many potentially important confounding factors were not reported (eg, comorbidities, sociodemographics, allergies).
Conclusions
This systematic review and meta-analysis found no evidence to support the routine use of postoperative antibiotic prophylaxis in rhinoplasty. Like most surgical procedures, however, rhinoplasty is a heterogeneous operation in terms of scope, incisions, length of surgery, and use of grafts or foreign materials. These factors were not explored rigorously in this or other studies. It shall remain important to be vigilant regarding infection risk, and the above recommendations are not a replacement for clinical judgment on a case-by-case basis.
